The Role of Microbiota in Pancreatic Cancer and Precursor Lesions
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHerlev Hospital
About this trial
This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response.
Participants will be asked to complete a questionnaire, provide oral and fecal swabs, and-if clinically indicated-1-2 pancreatic biopsies will be collected.
Eligibility criteria
Qualifiers
Patients with a suspected lesion (solid/cystic) in the pancreas undergoing diagnostic or therapeutic endoscopic procedure
Age of 18 years or above
Signed informed consent form
Disqualifiers
Contraindications for endoscopic or surgical procedure, such as uncorrected coagulopathy
Trial design
Treatments tested in this trial
- observational study
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
Herlev Hospital
Lead sponsor
Danish Cancer Society
Collaborator
Source ClinicalTrials.gov